Insider filing · ACRV
Perceptive Advisors Llc sold $2.7M of Acrivon Therapeutics (ACRV)
Executed Apr 25 2025, disclosed Apr 29 2025, 4 days later.
Value, as filed
$2.7M
1,519,952 sh across 3 lots
Executed
Apr 25 2025
the trade date, as filed
Disclosed
Apr 29 2025
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
PL
Perceptive Advisors Llc
Director
profile →
Perceptive Advisors Llc (Director) filed 2 Form 4 reports as a reporting entity in the trailing twelve months (1 purchase, 1 sale), most often in ACRV. The largest single filing was $7.5M of IMTX (863,060 sh × $8.69, as filed), executed Aug 26. The median gap between execution and disclosure was 1 day.
The name
ACRV
ACRV
ACRV · 2 filings in 24 months
ticker →
Insider filings, newest first→
View the original filing at www.sec.gov→
Other filings by Perceptive Advisors Llc in ACRV
ACRVSALE
Acrivon Therapeutics, Inc.
$1.0M736,767 sh across 2 lots
Exec Apr 30 2025
Filed May 1 2025 · 5:30 PM ET